MyAverix Finance
US · Healthcare
Curanex Pharmaceuticals Inc Common Stock (CURX)
Biotechnology
Curanex Pharmaceuticals Inc Common Stock (CURX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-19, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CURX
Curanex Pharmaceuticals Inc Common Stock (CURX) — FAQ
What is CURX's P/E ratio?
The price-to-earnings (P/E) ratio for Curanex Pharmaceuticals Inc Common Stock (CURX) is 25.00 (data as of 2026-05-19).
Does Curanex Pharmaceuticals Inc Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Curanex Pharmaceuticals Inc Common Stock (CURX). Check the MyAverix Finance app for the latest dividend data.
What sector is Curanex Pharmaceuticals Inc Common Stock in?
Curanex Pharmaceuticals Inc Common Stock (CURX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CURX listed on?
CURX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.